Who is sponsoring NCT03577964?

NCT03577964 is sponsored by University of Ulm.

What drugs are being tested in NCT03577964?

Interventions in NCT03577964: Glucose Measurements,.

What condition does NCT03577964 study?

NCT03577964 studies Glucose Metabolism Disorders, Pneumonia, Bacterial.

Is NCT03577964 still recruiting?

NCT03577964 is currently status unknown. Last updated 26 April 2019.

Last reviewed 2019-04-26 · How we verify

NCT03577964

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia

Status unknown Last updated 26 April 2019

What this trial tests

trial testing Glucose Measurements, in Glucose Metabolism Disorders in 61 participants. Status unknown.

Timeline

1 September 2017

Primary endpoint
25 April 2019

25 April 2020

Quick facts

Lead sponsor	University of Ulm
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	61
Start date	1 September 2017
Primary completion	25 April 2019
Estimated completion	25 April 2020
Sites	1 location across Germany

Drugs / interventions tested

Glucose Measurements,

Conditions studied

Glucose Metabolism Disorders — all drugs for Glucose Metabolism Disorders →
Pneumonia, Bacterial — all drugs for Pneumonia, Bacterial →

Sponsor

University of Ulm

Who can join

18 and older, any sex, with Glucose Metabolism Disorders or Pneumonia, Bacterial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Incidence of Pneumonia in Patients with high systemic glucose levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Glucose Metabolism Disorders

Currently open trials in the same condition.

NCT06763562 — Food Orders on Blood Glucose and Fuel Use At Rest · NA · recruiting
NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
NCT06051318 — Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy Subjects · NA · recruiting
NCT06358716 — Glycaemic Index Determination in Oral Nutrition Supplements · NA · recruiting
NCT06878781 — Postprandial Metabolome and Metabolic Flexibility · NA · recruiting

Other University of Ulm trials

Trials by the same sponsor.

NCT07436195 — Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA · recruiting
NCT07154524 — Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) · recruiting
NCT06877143 — Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis · NA · recruiting
NCT06280079 — Ultra-high-caloric, Fatty Diet in ALS · NA · recruiting
NCT06627348 — Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03577964 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Ulm
Last refreshed: 26 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03577964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing